|
Eine Ebene nach oben |
Gruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Springe zu: 2016
Anzahl der Publikationen: 4
2016
Brendel, M.; Jaworska, A.; Lindner, S.; Gildehaus, F.; Albert, Nathalie L. 
ORCID: https://orcid.org/0000-0003-0953-7624; Beck, R.; Bartenstein, P.; Herms, J.; Kleinberger, G.; Haass, C. und Rominger, A.
(2016):
Microglia, Amyloidosis and TREM2 Progress in Parallel during the Life Course of PS2APP Mice.
EANM '16, 29th Annual Congress of the European Association of Nuclear Medicine, Barcelona, Spain, October 15–19, 2016.
European Journal of Nuclear Medicine and Molecular Imaging.
Bd. 43, Nr. S1
Springer.
S100-S100
ORCID: https://orcid.org/0000-0003-0953-7624; Beck, R.; Bartenstein, P.; Herms, J.; Kleinberger, G.; Haass, C. und Rominger, A.
(2016):
Microglia, Amyloidosis and TREM2 Progress in Parallel during the Life Course of PS2APP Mice.
EANM '16, 29th Annual Congress of the European Association of Nuclear Medicine, Barcelona, Spain, October 15–19, 2016.
European Journal of Nuclear Medicine and Molecular Imaging.
Bd. 43, Nr. S1
Springer.
S100-S100
Mazaheri, F.; Kleinberger, G.; Daria, A.; Werner, G.; Tahirovic, S.; Truembach, D.; Bultmann, S.; Butovsky, O. und Haass, C.
(2016):
Role of Trem2 in Neurodegeneration: A systems biology approach.
In: Journal of Neurochemistry, Bd. 138: S. 411
Xiang, X.; Werner, G.; Bohrmann, B.; Mazaheri, F.; Capell, A.; Feederle, R.; Knuesel, I.; Kleinberger, G. und Haass, C.
(2016):
TREM2-deficiency reduces the efficacy of immunotherapeutic amyloid clearance.
In: Journal of Neurochemistry, Bd. 138: S. 422
Kleinberger, G.; Wefers, B.; Suarez-Calvet, M.; Mazaheri, F.; Todorov, A.; Brendel, M.; Mracsko, E.; Wurst, W.; Mueggler, T.; Rominger, A.; Knuesel, I. und Haass, C.
(2016):
A mouse model for FTD-like syndrome due to TREM2 mutations.
In: Journal of Neurochemistry, Bd. 138: S. 248